Boston Scientific (BSX) Earnings Analysis

Boston Scientific (BSX) next reports earnings on 2026-07-29, consensus EPS 0.828 USD. Last quarter (2026-04-22) it beat with EPS 0.8 USD vs 0.788 USD est (+1.5%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 17.90.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BSX next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate0.828 USD
Revenue estimate5.37B

BSX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-220.8 USD0.788 USD+1.5%Beat
2026-02-040.8 USD0.781 USD+2.4%Beat
2025-10-220.75 USD0.714 USD+5%Beat
2025-07-230.75 USD0.725 USD+3.4%Beat
2025-02-050.7 USD0.657 USD+6.5%Beat
2024-07-240.62 USD0.583 USD+6.3%Beat

Beat rate: 6/6 (100%) over reported quarters with consensus data.

BSX valuation and analyst view

Trailing P/E17.90
Trailing EPS2.393 USD
Price / book2.47
Dividend yield0.00%
Market cap63.73B
Analyst consensusBuy (39 buy / 5 hold / 0 sell)
Avg price target68.72 USD

Related research pages

Frequently asked questions

When is Boston Scientific (BSX)'s next earnings date?

Boston Scientific is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 0.828 USD and revenue estimate of 5.37B.

Did BSX beat earnings last quarter?

In its 2026-04-22 report, BSX posted EPS of 0.8 USD versus a 0.788 USD estimate — a beat of 1.5%.

What is BSX's earnings track record?

Over the last 6 reported quarters with consensus data, BSX beat estimates 6 times (100%).

What is BSX's current P/E ratio and EPS?

BSX trades at a trailing P/E of 17.90 on trailing EPS of 2.392753720789279 USD.

What do analysts rate BSX?

Analyst consensus is "Buy" across 44 ratings (1 strong buy, 38 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 68.72 USD.